Qingdao Baheal Medical Future Growth
Future criteria checks 3/6
Qingdao Baheal Medical is forecast to grow earnings and revenue by 21.5% and 11.1% per annum respectively. EPS is expected to grow by 21.4% per annum. Return on equity is forecast to be 26.5% in 3 years.
Key information
21.5%
Earnings growth rate
21.4%
EPS growth rate
| Healthcare earnings growth | 23.6% |
| Revenue growth rate | 11.1% |
| Future return on equity | 26.5% |
| Analyst coverage | Low |
| Last updated | 05 Oct 2024 |
Recent future growth updates
No updates
Recent updates
Many Would Be Envious Of Qingdao Baheal Medical's (SZSE:301015) Excellent Returns On Capital
Oct 21
It's Down 25% But Qingdao Baheal Medical INC. (SZSE:301015) Could Be Riskier Than It Looks
Jun 30Qingdao Baheal Medical (SZSE:301015) Looks To Prolong Its Impressive Returns
Jun 21Qingdao Baheal Medical (SZSE:301015) Has Affirmed Its Dividend Of CN¥0.762
May 26Qingdao Baheal Medical (SZSE:301015) Has A Rock Solid Balance Sheet
May 21Many Would Be Envious Of Qingdao Baheal Medical's (SZSE:301015) Excellent Returns On Capital
Mar 01Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 11,229 | 1,319 | N/A | 1,043 | 5 |
| 12/31/2025 | 9,663 | 1,073 | N/A | 789 | 5 |
| 12/31/2024 | 8,399 | 851 | N/A | 730 | 5 |
| 12/31/2023 | 7,889 | 654 | N/A | 775 | 4 |
| 9/30/2023 | 7,975 | 703 | 393 | 531 | N/A |
| 6/30/2023 | 7,414 | 588 | 377 | 492 | N/A |
| 3/31/2023 | 7,336 | 537 | 470 | 589 | N/A |
| 12/31/2022 | 7,510 | 502 | 200 | 306 | N/A |
| 9/30/2022 | 7,336 | 458 | 327 | 411 | N/A |
| 6/30/2022 | 7,436 | 451 | 264 | 314 | N/A |
| 3/31/2022 | 7,286 | 423 | 136 | 170 | N/A |
| 1/1/2022 | 7,052 | 422 | 154 | 181 | N/A |
| 9/30/2021 | 7,038 | 421 | 524 | 543 | N/A |
| 6/30/2021 | 6,797 | 349 | 210 | 228 | N/A |
| 3/31/2021 | 6,291 | 303 | -66 | -51 | N/A |
| 12/31/2020 | 5,879 | 273 | -133 | -117 | N/A |
| 12/31/2019 | 4,849 | 210 | 40 | 43 | N/A |
| 12/31/2018 | 3,652 | 258 | 37 | 53 | N/A |
| 12/31/2017 | 3,096 | 222 | 149 | 160 | N/A |
| 12/31/2016 | 3,034 | 184 | N/A | 88 | N/A |
| 12/31/2015 | 2,392 | 73 | N/A | 82 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 301015's forecast earnings growth (21.5% per year) is above the savings rate (2.9%).
Earnings vs Market: 301015's earnings (21.5% per year) are forecast to grow slower than the CN market (25.7% per year).
High Growth Earnings: 301015's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 301015's revenue (11.1% per year) is forecast to grow slower than the CN market (14% per year).
High Growth Revenue: 301015's revenue (11.1% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 301015's Return on Equity is forecast to be high in 3 years time (26.5%)